Yatharth Hospital & Trauma Care Services Ltd

AI
Yatharth Hospit. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Yatharth Hospital & Trauma Care Services Ltd

₹ 986 5.07%
03 Nov 2:35 p.m.
yatharthhospitals.com BSE: 543950 NSE: YATHARTH
About

Incorporated in 2008, Yatharth Hospital and Trauma Care Services Limited is a multi-care hospitals at Noida, Greater Noida, and Noida Extension, Uttar Pradesh.[1]

Key Points

Hospital Portfolio:[1]
Yatharth operates a network of multi-specialty and super-specialty hospitals primarily in North India, focusing on tertiary care, trauma services, and advanced treatments.
The company operates 9 hospitals with
total bed capacity exceeding 2,800 beds
and maintains 12 Centres of Excellence
across specialties. The 80% of beds are
located in metro cities, providing access
to high-demand healthcare markets.[2]

Website BSE NSE
  • Market Cap ₹ 9,505 Cr.
  • Current Price ₹ 986
  • High / Low ₹ 1,184 / 538
  • Stock P/E 98.5
  • Book Value ₹ 168
  • Dividend Yield 0.05 %
  • ROCE 8.01 %
  • ROE 5.85 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is expected to give good quarter
  • Company's working capital requirements have reduced from 340 days to 99.0 days

Cons

  • Stock is trading at 5.81 times its book value
  • Company has a low return on equity of 8.02% over last 3 years.
  • Promoter holding has decreased over last 3 years: -10.5%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of Nifty Microcap 250 BSE Healthcare BSE 1000 BSE Hospitals Nifty Smallcap 500

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
102 110 102 106 119 113 110 112 130 137 158 164 176
73 79 72 78 86 82 79 80 95 110 122 125 136
Operating Profit 29 31 29 28 33 31 32 32 35 27 37 39 40
OPM % 28% 28% 29% 26% 28% 27% 29% 28% 27% 20% 23% 24% 23%
0 3 5 5 3 2 3 4 7 6 5 7 13
Interest 2 2 0 0 0 0 0 0 0 0 1 4 5
Depreciation 3 3 4 3 4 5 5 5 5 6 9 10 10
Profit before tax 24 30 30 29 31 27 30 31 37 27 32 31 38
Tax % 35% 30% 30% 10% 26% 26% 25% 29% 28% 22% 26% 23% 26%
16 21 21 26 23 20 22 22 27 21 24 24 28
EPS in Rs 2.38 2.45 2.46 3.06 2.70 2.38 2.31 2.27 2.81 2.14 2.48 2.47 2.92
Raw PDF
Upcoming result date: today

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
71 78 91 123 165 278 331 394 444 580 636
53 59 72 92 120 193 225 275 312 434 493
Operating Profit 18 18 20 31 45 85 106 119 132 146 143
OPM % 25% 24% 22% 25% 27% 31% 32% 30% 30% 25% 22%
0 0 0 0 1 1 2 14 9 23 32
Interest 6 5 6 14 13 13 10 6 4 11 11
Depreciation 7 6 8 15 14 13 13 13 19 30 36
Profit before tax 5 8 6 3 18 60 86 113 119 127 128
Tax % 41% 23% 51% 72% 31% 30% 25% 26% 27% 25%
3 6 3 1 12 42 64 84 88 95 96
EPS in Rs 0.55 0.94 0.44 0.12 1.88 6.42 9.79 9.78 9.10 9.90 10.01
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 29%
3 Years: 21%
TTM: 37%
Compounded Profit Growth
10 Years: %
5 Years: 49%
3 Years: 13%
TTM: 5%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 37%
1 Year: 15%
Return on Equity
10 Years: 10%
5 Years: 11%
3 Years: 8%
Last Year: 6%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 14 16 16 16 16 66 66 86 96 96
Reserves 24 32 39 40 53 46 111 751 1,429 1,523
85 107 120 113 103 115 117 5 7 235
10 11 22 32 39 59 33 36 42 87
Total Liabilities 133 166 197 202 211 286 326 878 1,575 1,941
51 47 146 134 132 122 121 133 161 393
CWIP 54 80 0 0 0 0 0 0 153 18
Investments 7 19 28 33 34 47 47 67 234 534
20 20 22 34 45 117 159 679 1,026 996
Total Assets 133 166 197 202 211 286 326 878 1,575 1,941

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
25 19 21 24 26 27 26 16 95 95
-45 -39 -36 -8 -4 -18 -9 -167 -557 -383
21 21 11 -20 -23 -7 -6 241 602 215
Net Cash Flow 1 2 -4 -4 -1 1 11 89 140 -73
Free Cash Flow 24 18 -86 20 23 21 17 -18 -108 -21
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 135% 113% 114% 82% 59% 43% 54% 44% 81% 95%

Ratios

Standalone / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 58 44 51 54 70 100 95 133 140 129
Inventory Days 47 42 44 37 33 40 28
Days Payable 127 106 224 161 154 47 154
Cash Conversion Cycle -22 -20 -129 -70 -51 100 95 133 133 3
Working Capital Days 20 7 -15 -7 7 26 85 373 548 99
ROCE % 9% 7% 10% 18% 37% 37% 21% 10% 8%

Insights

In beta
Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
ALOS (Average Length of Stay)
days

Log in to view insights

Please log in to see hidden values.

Login
ARPOB (Average Revenue Per Occupied Bed)
Rs
Bed Occupancy Rate
%
IPD Volume
'000 (thousands)
Number of Operational Hospitals
count
OPD Volume
'000 (thousands)
Operational Bed Capacity
beds
Operational Census Beds
beds

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
66.44% 66.54% 66.54% 66.54% 61.44% 61.64% 61.64% 61.64% 55.80% 55.80% 55.80% 55.80%
2.59% 3.99% 4.90% 6.28% 9.78% 4.45% 4.34% 6.51% 6.18% 5.25% 5.62% 7.05%
8.81% 9.30% 9.40% 6.97% 11.50% 13.56% 13.52% 8.71% 11.02% 12.00% 10.84% 10.94%
22.15% 20.15% 19.16% 20.20% 17.27% 20.35% 20.50% 23.16% 27.01% 26.94% 27.74% 26.21%
No. of Shareholders 51,74346,56751,91662,61673,25185,66881,44091,43496,22199,11796,26499,397

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls